Marco A. Peña Duque – President, Mexican Society of Cardiology
The president of the Mexican Society of Cardiology sat down with us to share his view of the cardiology medical field in the country, why Mexico needs to collaborate more…
Founded in 1947, Santamarina y Steta offers legal solidity in the business environment based on extensive knowledge and experience in a large variety of local and international affairs. The firm focuses on a staff of more than 90 lawyers, more than 30 areas of specialization as well as almost 1000 active clients in the private sector, government organizations and non-profit organizations, with local and international investment. Healthcare and Life Sciences is one of the business sectors the firm focuses on and for many years now, Santamarina y Steta has nurtured a growing practice for assisting clients operating in the pharmaceutical and healthcare industry in complying with Mexican health-related regulation.
+52 (55) 5279 5400
Website: www.s-s.mx
The president of the Mexican Society of Cardiology sat down with us to share his view of the cardiology medical field in the country, why Mexico needs to collaborate more…
Novartis strives for “creating solutions for patients that go beyond the pill”. The country head and next president of CANIFARMA discusses how the company is using new programs and technology…
Considered one of the leading medical authorities in the country, David Kershenobich provides an overview about the new challenges faced by the Mexican healthcare system with the transition from infectious…
Thanks to the recognition COFEPRIS received from the Pan-American Health Organization as national regulatory authority of regional reference, Mexican manufacturers are increasingly eyeing foreign markets to grow. The general manager…
Healthcare is one of the next items on President Peña Nieto’s busy agenda. The objective: moving Mexico towards universal healthcare coverage. The initiative was started at the beginning of 2000…
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Dr. José Angel Cordova Villalobos shares his experience as former Minister of Health and illustrates how the unification of today’s fragmented healthcare system is the only way to provide effective…
The opening of the Mexican Social Security Institute (IMSS) to clinical research is a unique opportunity for Mexico to step up on the international scenario for clinical trials. The CEO of…
Store brands are Perrigo’s core business. The vice president and managing director of the Mexican and Latin American affiliate discusses the company’s pioneer and early vision to bet on generics…
The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to…
The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand…
Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health…
See our Cookie Privacy Policy Here
